retatrutide fda approval status 2025 Before Approval? Lilly Just Changed the Conversation Retatrutide FDA Approval: What 2025-2026

& Akhavan-Niaki, H

Common side effects include fluid retention (swelling in the legs or ankles), weight gain, and an increased risk of bone fractures

Additionally, any significant weight loss typically includes lean mass loss alongside fat, a clinically meaningful risk that requires protein guidance from a registered dietitian and resistance-training support

This process increases levels of IGF-1, a hormone linked to protein synthesis, muscle development, and overall rejuvenation

Machine intelligence in peptide therapeutics: a next-generation tool for rapid disease screening

Newsome P, Francque S, Harrison S et al